ask="45.90"
ask_size="200"
average_daily_volume="375402"
bid="N/A"
bid_size="N/A"
book_value="14.89"
change="-0.09"
change_from_200_day_moving_average="-4.04"
change_from_50_day_moving_average="-1.29"
change_from_52_week_high="-14.95"
change_From_52_week_low="17.99"
change_in_percent="-0.20%"
close="46.03"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="8.95"
ebitda="267.62M"
eps_estimate_current_year="-2.27"
eps_estimate_next_quarter="-0.74"
eps_estimate_next_year="-3.15"
ex_dividend_date="N/A"
float_shares="23962000"
high="46.75"
high_52_weeks="60.98"
last_trade_date="2/14/2017"
last_trade_price="46.03"
last_trade_size="20778"
last_trade_time="4:00pm"
low="45.32"
low_52_weeks="28.04"
market_capitalization="1.25B"
moving_average_200_day="50.07"
moving_average_50_day="47.32"
name="Five Prime Therapeutics
Inc."
notes="N/A"
one_year_target_price="60.17"
open="45.70"
pe_ratio="5.14"
peg_ratio="0.34"
percent_change_from_200_day_moving_average="-8.08%"
percent_change_from_50_day_moving_average="-2.72%"
percent_change_from_52_week_high="-24.52%"
percent_change_from_52_week_low="+64.16%"
previous_close="46.12"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="3.10"
price_per_sales="3.24"
revenue="385.77M"
shares_outstanding="27138000"
short_ratio="6.80"
stock_exchange="NMS"
symbol="FPRX"
volume="246979"
weeks_range_52="28.04 - 60.98"
